Jean Labrecque is a scientific leader with a strong strategic/business perspective in R&D and has more than 17 years’ experience in management in the Pharma & Biopharma industry. A courageous leader with proven experience in building strong and highly engaged research teams. Seen has a leader in innovation and a molecular pharmacology expert who provides mentoring to others in a broad range of target class (GPCR, Ion channel, enzymes). A strong contributor to multiple aspects of preclinical research (CRO management, due diligence for in-licensing, basic research, applied drug discovery: target validation, medicinal chemistry, pharmacology, and all preclinical aspects of drug discovery). Experience in managing and coordinating the in vitro biology component of research in CNS (neurology, pain & inflammation) and in cancer (biologics) for program ranging from target identification to lead optimization. As a manager of the translational department at National Research Council of Canada in human heath therapeutic, Jean has developed cross-functional skills and built strong relationships with team members from cell biology, antibody discovery/engineering, advanced analytics, downstream and upstream processes, CMC, protein chemistry, safety, translational sciences and in vivo biology. Managed various teams in assay development, cell & molecular biology, in vitro profiling/screening and electrophysiology and high-throughput screening. Experience in governance process in biosafety, biosecurity, radioprotection program, capital asset management (instrument) and active member in various global business reference group (R&D career pathways, biosecurity risk registry, mammalian cells forum, ion channel initiative, CNSP R&D informatics forum). PhD in Pharmacology, postdoctoral work at AZ R&D Montreal. Goal: Develop and contribute to highly effective drug/biologic discovery team that will deliver innovative therapeutic to address unmet medical needs and impact positively patient health.